BNVA 150 (Boniva 150 mg)
Generic Name: ibandronate
Pill with imprint BNVA 150 is White, Elliptical/Oval and has been identified as Boniva 150 mg. It is supplied by Roche Laboratories.
Boniva is used in the treatment of osteoporosis; prevention of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Boniva 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BNVA 150
Boniva
- Generic Name
- ibandronate
- Imprint
- BNVA 150
- Strength
- 150 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Roche Laboratories
- Inactive Ingredients
-
lactose monohydrate,
povidone k25,
microcrystalline cellulose,
stearic acid,
silicon dioxide,
titanium dioxide,
magnesium silicate,
polyethylene glycol 6000
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00004-0186 | Roche |
| 54868-5322 (Discontinued) | Physicians Total Care Inc. (repackager) |
| 35356-0423 | Lake Erie Medical and Surgical Supply (repackager) |
More about Boniva (ibandronate)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (85)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: bisphosphonates
- FDA approval history
Patient resources
- Drug Information
- Boniva (Advanced Reading)
- Boniva Intravenous (Advanced Reading)
- Boniva (Ibandronate Injection)
- Boniva (Ibandronate Tablets)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.